stock rating
Wolfe Research Upgrades Danaher to Outperform
The upgrade is based on the firm's improving growth, more reasonable valuations, and its ability to deploy capital.
UBS Initiates Coverage of Veracyte With Buy Rating
Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.
Barclay's Initiates Coverage of Bruker With Overweight Rating
The bank believes new launches from the company's legacy portfolio combined with acquisitions should keep its growth above that of its peers in the space.
Barclays Upgrades Revvity to Overweight
The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.
Jefferies Upgrades Waters to Buy Rating, Raises Price Target to $415
The upgrade is based on the bank's belief that a liquid chromatography-mass spectrometry replacement cycle is underway.
May 15, 2024
BTIG Downgrades Ginkgo Bioworks to Sell Rating
Jan 4, 2024
TD Cowen Downgrades Illumina to Market Perform
Dec 22, 2023
Wells Fargo Initiates Coverage of Revvity
Jul 31, 2023
Evercore, Barclays Downgrade Agilent Shares
Dec 6, 2022
Cowen Upgrades PerkinElmer Stock to Outperform
Sep 28, 2022